10
Participants
Start Date
June 30, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Warfarin
Oral administration (QD), variable dosage: patients will undergo blood test for PT/INR at baseline and afterwards, at weekly bases for 4 weeks. The INR will be kept in a safe range of 2-2.5
Cooper University Hospital, Camden
The Cooper Health System
OTHER